Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Hea...

IQVIA Holdings Inc. (IQV) has a valuation score of 90/100 (strong), profitability score of 57/100 (moderate), financial health score of 31/100 (weak), Piotroski F-Score of 5/9, Altman Z-Score of 1.62 (distressed), revenue growth of +4.2% YoY.

Neutral

Analyst Consensus

Strong Buy

Wall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026

Analyst Recommendations28 analysts · 2026-08-01
8
14
6
Strong Buy 8Buy 14Hold 6Sell 0Strong Sell 0

Recent Market Moves

See all IQV moves →
DateSessionPriceMoveZ-Score
Aug 6Pre-market$236.05+3.45%2.30
Aug 5Regular$236.24+3.52%2.35
Aug 5After-hours$236.08+3.45%2.30
IQVIA Holdings Inc. (IQV) Valuation & P/E History →IQVIA Holdings Inc. (IQV) Financial Statements →
Share:

Explore More Stocks

AAPLMSFTNVDAGOOGLAMZNMETATSLAJPMWMTVView all stocks →